Assembly Bill 170, introduced in the Nevada State Legislature on March 2, 2025, aims to regulate the practice of associate physicians, particularly concerning their ability to prescribe controlled substances. The bill seeks to address the growing need for healthcare providers in Nevada while ensuring patient safety and proper oversight.

The main provisions of AB170 include restrictions on the prescription of controlled substances by associate physicians. Specifically, the bill limits these practitioners to prescribing a maximum of a five-day supply of Schedule II or III controlled substances, with an exception for buprenorphine, which can be prescribed for up to 30 days for treating substance use disorders under supervision. Furthermore, it mandates that an associate physician can only prescribe controlled substances if their supervising physician is physically present or if they have completed a minimum of 120 hours of practice under supervision within four months.

The bill also outlines the licensing process for associate physicians, including a two-year expiration for limited licenses and requirements for renewal, which necessitate proof of active practice under a collaborative agreement. The Nevada Board of Medical Examiners is tasked with adopting regulations to implement these provisions, including setting standards for postgraduate medical education and supervision.

Debate surrounding AB170 has focused on the balance between expanding access to healthcare and ensuring adequate supervision to protect patients. Supporters argue that the bill will help alleviate physician shortages, particularly in underserved areas, while critics express concerns about the potential risks of allowing less experienced practitioners to prescribe controlled substances without sufficient oversight.

The implications of AB170 are significant, as it could reshape the landscape of healthcare delivery in Nevada. By enabling associate physicians to practice more independently, the bill may improve access to care, particularly in rural communities. However, the effectiveness of these measures will depend on the successful implementation of oversight regulations and the ongoing collaboration between associate physicians and their supervising doctors.

As the legislative process continues, stakeholders will be closely monitoring the discussions and potential amendments to ensure that the bill meets the needs of both healthcare providers and patients in Nevada.